Arrowhead Pharmaceuticals Inc (ARWR)

62.99 +5.97  +10.47% NASDAQ Nov 27, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/05/2021 Earnings Arrowhead Pharmaceuticals Inc First Quarter Earnings for 2021 Release
02/05/2021 16:30 EST Misc Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 2021
11/23/2020 Earnings Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Result for 2020
11/23/2020 16:30 EST Misc Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020
11/23/2020 Misc Arrowhead Pharmaceuticals Inc Annual Report for 2020
08/05/2020 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Arrowhead Pharmaceuticals Inc Third Quarter Earnings Result for 2020
05/07/2020 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020
05/07/2020 Earnings Arrowhead Pharmaceuticals Inc Second Quarter Earnings Result for 2020
03/19/2020 10:00 PDT Misc Arrowhead Pharmaceuticals Inc Annual General Meeting for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.arrowheadpharma.com
  • Investor Relations URL: http://ir.arrowheadpharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 05, 2021
  • Last Earnings Release: Nov. 23, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Top Fund Holders

Symbol Name Weighting
SBIO ALPS Medical Breakthroughs ETF 3.98%
GOFFX Invesco Global Opp R5 1.72%
XBI SPDR® S&P Biotech ETF 1.55%
RFG Invesco S&P MidCap 400® Pure Growth ETF 1.41%
BIOUX Baron Opportunity R6 1.24%
VRTGX Vanguard Russell 2000 Growth Index I 0.58%
VTWG Vanguard Russell 2000 Growth ETF 0.58%
IWO iShares Russell 2000 Growth ETF 0.50%
VRTIX Vanguard Russell 2000 Index I 0.30%
VTWO Vanguard Russell 2000 ETF 0.30%
MDSKX iShares Russell 2000 Small-Cap Idx Inv A 0.30%
SWSSX Schwab Small Cap Index 0.30%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.